BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15081430)

  • 1. Comparison of WNK4 and WNK1 kinase and inhibiting activities.
    Wang Z; Yang CL; Ellison DH
    Biochem Biophys Res Commun; 2004 May; 317(3):939-44. PubMed ID: 15081430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases.
    Vitari AC; Deak M; Morrice NA; Alessi DR
    Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WNK1 and WNK4 modulate CFTR activity.
    Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WNK-SPAK-NCC cascade revisited: WNK1 stimulates the activity of the Na-Cl cotransporter via SPAK, an effect antagonized by WNK4.
    Chávez-Canales M; Zhang C; Soukaseum C; Moreno E; Pacheco-Alvarez D; Vidal-Petiot E; Castañeda-Bueno M; Vázquez N; Rojas-Vega L; Meermeier NP; Rogers S; Jeunemaitre X; Yang CL; Ellison DH; Gamba G; Hadchouel J
    Hypertension; 2014 Nov; 64(5):1047-53. PubMed ID: 25113964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary electrolyte-driven responses in the renal WNK kinase pathway in vivo.
    O'Reilly M; Marshall E; Macgillivray T; Mittal M; Xue W; Kenyon CJ; Brown RW
    J Am Soc Nephrol; 2006 Sep; 17(9):2402-13. PubMed ID: 16899520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the expression of the Na/Cl cotransporter by WNK4 and WNK1: evidence that accelerated dynamin-dependent endocytosis is not involved.
    Golbang AP; Cope G; Hamad A; Murthy M; Liu CH; Cuthbert AW; O'shaughnessy KM
    Am J Physiol Renal Physiol; 2006 Dec; 291(6):F1369-76. PubMed ID: 16788137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WNK kinases regulate thiazide-sensitive Na-Cl cotransport.
    Yang CL; Angell J; Mitchell R; Ellison DH
    J Clin Invest; 2003 Apr; 111(7):1039-45. PubMed ID: 12671053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney-specific WNK1 isoform (KS-WNK1) is a potent activator of WNK4 and NCC.
    Argaiz ER; Chavez-Canales M; Ostrosky-Frid M; Rodríguez-Gama A; Vázquez N; Gonzalez-Rodriguez X; Garcia-Valdes J; Hadchouel J; Ellison D; Gamba G
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F734-F745. PubMed ID: 29846116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
    Yang CL; Zhu X; Ellison DH
    J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
    Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
    J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of WNK1 and implications for other family members.
    Lenertz LY; Lee BH; Min X; Xu BE; Wedin K; Earnest S; Goldsmith EJ; Cobb MH
    J Biol Chem; 2005 Jul; 280(29):26653-8. PubMed ID: 15883153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of WNK1 by an autoinhibitory domain and autophosphorylation.
    Xu BE; Min X; Stippec S; Lee BH; Goldsmith EJ; Cobb MH
    J Biol Chem; 2002 Dec; 277(50):48456-62. PubMed ID: 12374799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-sensitive NaCl cotransport.
    Yang CL; Zhu X; Wang Z; Subramanya AR; Ellison DH
    J Clin Invest; 2005 May; 115(5):1379-87. PubMed ID: 15841204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased ENaC expression compensates the increased NCC activity following inactivation of the kidney-specific isoform of WNK1 and prevents hypertension.
    Hadchouel J; Soukaseum C; Büsst C; Zhou XO; Baudrie V; Zürrer T; Cambillau M; Elghozi JL; Lifton RP; Loffing J; Jeunemaitre X
    Proc Natl Acad Sci U S A; 2010 Oct; 107(42):18109-14. PubMed ID: 20921400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intersectin links WNK kinases to endocytosis of ROMK1.
    He G; Wang HR; Huang SK; Huang CL
    J Clin Invest; 2007 Apr; 117(4):1078-87. PubMed ID: 17380208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WNK kinases influence TRPV4 channel function and localization.
    Fu Y; Subramanya A; Rozansky D; Cohen DM
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1305-14. PubMed ID: 16403833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of WNK4 and kidney-specific WNK1 in mediating the effect of high dietary K
    Wu P; Gao ZX; Su XT; Ellison DH; Hadchouel J; Teulon J; Wang WH
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F223-F230. PubMed ID: 29667910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic regulation of ROMK by long and kidney-specific WNK1 isoforms.
    Lazrak A; Liu Z; Huang CL
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1615-20. PubMed ID: 16428287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.